Cancer Stem Cells: A New Paradigm for Understanding Tumor Growth and Progression and Drug Resistance
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
1688-1703
Author(s):
Rosaria Gangemi, Laura Paleari, Anna Maria Orengo, Alfredo Cesario, Leonardo Chessa, Silvano Ferrini and Patrizia Russo
The Metastatic Process: Methodological Advances and Pharmacological Challenges
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
1704-1717
Author(s):
Antonio Mazzocca and Vinicio Carloni
Novel Implications for Lysophospholipids, Lysophosphatidic Acid and Sphingosine 1-Phosphate, as Drug Targets in Cancer
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
381-391
Author(s):
Olivier Peyruchaud
Cytotoxic and Anticancer Activities of Isatin and Its Derivatives: A Comprehensive Review from 2000-2008
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
397-414
Author(s):
K. L. Vine, L. Matesic, J. M. Locke, M. Ranson and D. Skropeta
Anticancer Actions of Omega-3 Fatty Acids - Current State and Future Perspectives
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
457-470
Author(s):
Martina Wendel and Axel R. Heller
Signaling Pathways of the ING Proteins in Apoptosis
Journal:
Current Drug Targets
Volume:
10
Page:
385-391
Author(s):
Sitar Shah and Karl Riabowol
Modulators of Inhibitor of Growth (ING) Family Expression in Development and Disease
Journal:
Current Drug Targets
Volume:
10
Page:
392-405
Author(s):
Stacey K. Maher and Caren C. Helbing
ING Proteins in Cellular Senescence
Journal:
Current Drug Targets
Volume:
10
Page:
406-417
Author(s):
Camino Menendez, Maria Abad, Daniel Gomez-Cabello, Alberto Moreno and Ignacio Palmero
The Return of the INGs, Histone Mark Sensors and Phospholipid Signaling Effectors
Journal:
Current Drug Targets
Volume:
10
Page:
418-431
Author(s):
Dennis J. Bua and Olivier Binda
ING Proteins as Potential Anticancer Drug Targets
Journal:
Current Drug Targets
Volume:
10
Page:
442-454
Author(s):
M. Unoki, K. Kumamoto and C. c. Harris